Acorda Therapeutics to Present at the UBS Warburg Global Life Sciences Conference

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR - News) today announced that Ron Cohen, M.D., President & CEO, will present a corporate overview at the upcoming UBS Global Life Sciences Conference on Monday, September 22, 2008 at 4:00 p.m. ET at the Grand Hyatt New York on Park Avenue at Grand Central Terminal in New York, NY.

MORE ON THIS TOPIC